Related Experiment Video
Updated: Jun 13, 2026
03:26
Acupuncture Treatment in a Mouse Model of Chronic Hypoxia-Induced Cognitive Dysfunction
Published on: December 8, 2023
N-acetylcysteine prevents memory deficits, the decrease in acetylcholinesterase activity and oxidative stress in rats
Jamile F Gonçalves1, Amanda M Fiorenza, Roselia M Spanevello
1Departamento de Bioquímica, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Rua Ramiro Barcellos, 2600-Anexo, Porto Alegre, RS, Brazil.
Chemico-Biological Interactions
|April 20, 2010
Summary
N-acetylcysteine (NAC) administration reversed cadmium-induced memory deficits in rats by restoring acetylcholinesterase (AChE) activity and reducing oxidative stress. NAC also mitigated cadmium
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Cadmium (Cd) exposure is linked to cognitive impairments and oxidative stress in the brain.
- Acetylcholinesterase (AChE) activity and lipid peroxidation are key indicators of neurotoxicity.
- N-acetylcysteine (NAC) is an antioxidant with potential neuroprotective properties.
Purpose of the Study:
- To investigate the effects of NAC on memory, AChE activity, and lipid peroxidation in cadmium-exposed rats.
- To determine if NAC can counteract cadmium-induced neurotoxicity and cognitive deficits.
- To explore NAC's impact on cholinergic neurotransmission and oxidative stress markers in specific brain regions.
Main Methods:
- Rats were exposed to cadmium (Cd) and/or treated with N-acetylcysteine (NAC) for 30 days.
- Behavioral tests (step-down latency) assessed memory function.
- AChE activity and TBARS levels (lipid peroxidation marker) were measured in brain homogenates.
- Serum urea and creatinine levels were analyzed to assess renal function.
Main Results:
- Cadmium exposure decreased memory performance and AChE activity while increasing lipid peroxidation in the hippocampus, cerebellum, and hypothalamus.
- NAC administration reversed the memory impairment and normalized AChE activity and lipid peroxidation levels.
- NAC also mitigated the increase in serum urea and creatinine caused by cadmium exposure.
- No significant changes in shock sensitivity were observed in any group.
Conclusions:
- N-acetylcysteine (NAC) demonstrates significant neuroprotective effects against cadmium-induced toxicity.
- NAC treatment can prevent or reverse cognitive deficits associated with cadmium exposure by modulating cholinergic neurotransmission and reducing oxidative stress.
- NAC may be a potential therapeutic agent for mitigating the neurological consequences of heavy metal intoxication.
- Further research is warranted to fully elucidate the mechanisms and clinical applicability of NAC in neurotoxic conditions.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:23Role of Neurotransmitters in Memory
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...